EP2882442
AÐFERÐ VIÐ AÐ MEÐHÖNDLA KRABBA MEÐ ÞVÍ AÐ NOTA 3-(4-((4-(MORFÓLÍNÓMETÝL)BENSÝL)OXÝ)-1-OXÓÍSÓINDÓLÍN-2-ÝL)PÍPERIDÍN-2,6-DÍÓN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.8.2013EP published:
9.6.2021EP application number:
13751007.9
EP translation filed:
16.7.2021Grant published:
15.9.2021EPO information:
European Patent Register
Max expiry date:
7.8.2033Expiry date:
7.8.2026Next due date:
31.8.2026
Title:
METHODS OF TREATING CANCER USING 3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE
Timeline
Today
8.8.2013EP application
9.6.2021EP Publication
16.7.2021Translation submitted
15.9.2021Registration published
7.8.2026Expires
Owner
Name:
Celgene CorporationAddress:
86 Morris Avenue, Summit, NJ 07901, US
Inventor
Name:
SCHAFER, Peter, H.Address:
Belle Mead, NJ 08502, US
Name:
GANDHI, AnitaAddress:
Bernardsville, NJ 07924, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201261681447 PDate:
9.8.2012Country:
US
Number:
201261722727 PDate:
5.11.2012Country:
US
Classification
Categories:
A61K 31/5377, A61P 35/00, G01N 33/50, A61K 45/06, A61P 35/02, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 12.7.2021
Expires: 7.8.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.7.2022
Expires: 7.8.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.7.2023
Expires: 7.8.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 9.7.2024
Expires: 7.8.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 5.8.2025
Expires: 7.8.2026
Payer: Árnason Faktor ehf.